mark swallow phd: Live & Latest News Updates : Vimarsana.com

ReiThera expands large-scale viral vector production capabilities with opening of new manufacturing facility

/PRNewswire/ -- ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines...

ReiThera Srl: ReiThera expands large-scale viral vector production capabilities with opening of new manufacturing facility

- New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; - New facility will allow ReiThera

Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy

Two-stage collaboration aims to accelerate development of high-capacity manufacturing processes for AAV-based products and secure Coave's infrastructure needs to set up its process development

ReiThera Awarded Grant to Develop Next Generation Vaccines

/PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and...

ReiThera Srl: ReiThera Awarded Grant to Develop Next Generation Vaccines

Program funded by the Bill & Melinda Gates Foundation will use ReiThera's GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV ROME

Dunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies

/PRNewswire/ -- Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation...

Nouscom announces first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer

The Dementia Discovery Fund Appoints Luca Santarelli, M.D., a Proven Neuroscience Leader, as the New Chair of its Scientific Advisory Board

BOSTON and LONDON, May 5, 2021 /PRNewswire/ -- The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic

The Dementia Discovery Fund Significantly Enhances its Neuroscience R&D Expertise to Support its Portfolio

The Dementia Discovery Fund Significantly Enhances its Neuroscience R&D Expertise to Support its Portfolio